The Future of Healthcare AI
The Future of Healthcare AI
Podcast Description
Healthcare investment experts Devin O’Reilly and Paul Moskowitz interview CEOs and founders on the forefront of healthcare AI. Together, they explore the impacts of AI on healthcare, with a focus on the human experience, operational opportunities, and the future of drug discovery. Learn more about the Bain Capital global healthcare platform at https://www.baincapital.com/healthcare.
Podcast Insights
Content Themes
Examines the transformative effects of AI on healthcare including operational efficiencies, enhancing the human experience, and innovation in drug discovery. Episodes cover topics like the potential of generative AI for value-based care, optimizing physician workflows, and integrating ambient listening tools in healthcare environments.

Healthcare investment experts Devin O’Reilly and Paul Moskowitz interview innovators at the forefront of healthcare AI. Together, they explore the impacts of AI on healthcare, with a focus on the human experience, operational opportunities, and the future of drug discovery. Learn more about the Bain Capital global healthcare platform at https://www.baincapital.com/healthcare.
With a background in human genomics and a career devoted to patient safety, Aman leads ArisGlobal, an enterprise software company supporting safe, compliant, and efficient drug development. Driven by a collaborative, global, and tech-forward mindset, ArisGlobal unifies drug data to uncover patterns and enable smarter, faster decisions.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.